Page last updated: 2024-08-25

methotrexate and Diabetes Mellitus, Type 1

methotrexate has been researched along with Diabetes Mellitus, Type 1 in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (8.33)	18.7374
1990's	4 (33.33)	18.2507
2000's	6 (50.00)	29.6817
2010's	1 (8.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Audrain, M; Hamidou, MA; Hervier, B; Masseau, A; Mussini, JM	1
Abbassi, V; Henzke, A; Sobel, DO	1
Andreu, MA; Cassoux, N; Chapelon-Abric, C; Guilpain, P; Jaeger-Bizet, F; Le Thi Huong-Boutin, D; Lehoang, P; Nasica, X; Piette, JC; Wechsler, B	1
Altmeyer, P; Appelhans, C; Breuckmann, F; Harati, A; Kreuter, A; Rotterdam, S	1
Burkly, LC; Ehrenfels, BN; Jakubowski, A; Pepinsky, RB	1
Erickson, AR; Reddy, V; Vogelgesang, SA; West, SG	1
Weinblatt, ME	1
de Jong, EM; de Mare, S; Seyger, MM; van den Hoogen, FH; van Haelst, U	1
Saxon, A	2
Buckingham, BA; Sandborg, CI	1
Bennett, JM; Carbone, PP; Cummings, F; Falkson, G; Kalish, LA; Olson, JE; Taylor, SG; Tormey, DC	1

Reviews

1 review(s) available for methotrexate and Diabetes Mellitus, Type 1

Article	Year
Methotrexate in rheumatoid arthritis: toxicity issues. British journal of rheumatology, 1996, Volume: 35, Issue:5 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Diabetes Mellitus, Type 1; Humans; Liver; Lung; Methotrexate	1996

Trials

3 trial(s) available for methotrexate and Diabetes Mellitus, Type 1

Article	Year
Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus. Acta diabetologica, 2010, Volume: 47, Issue:3 Topics: Adolescent; Blood Glucose; Child; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Male; Methotrexate; Pilot Projects; Remission Induction	2010
A randomized trial of methotrexate in newly diagnosed patients with type 1 diabetes mellitus. Clinical immunology (Orlando, Fla.), 2000, Volume: 96, Issue:2 Topics: Adolescent; C-Peptide; Child; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Female; Glycated Hemoglobin; Humans; Insulin; Liver; Male; Methotrexate	2000
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Diabetes Mellitus, Type 1; Female; Fluorouracil; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Obesity; Prednisone; Prognosis; Random Allocation; Receptors, Estrogen; Risk; Tamoxifen	1985

Other Studies

8 other study(ies) available for methotrexate and Diabetes Mellitus, Type 1

Article	Year
Long-term efficacy of mycophenolate mofetil in a case of refractory antisynthetase syndrome. Joint bone spine, 2009, Volume: 76, Issue:5 Topics: Adult; C-Reactive Protein; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Mycophenolic Acid; Protoporphyria, Erythropoietic; Raynaud Disease	2009
[Bilateral optic neuropathy revealing systemic sarcoidosis]. La Revue de medecine interne, 2004, Volume: 25, Issue:10 Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Blindness; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Optic Atrophy; Optic Nerve Diseases; Prednisone; Sarcoidosis; Time Factors	2004
Failure of low-dose methotrexate in the treatment of scleredema diabeticorum in seven cases. Dermatology (Basel, Switzerland), 2005, Volume: 211, Issue:3 Topics: Adult; Aged; Dermatologic Agents; Diabetes Mellitus, Type 1; Female; Humans; Male; Methotrexate; Middle Aged; Scleroderma, Diffuse; Treatment Failure	2005
Vascular cell adhesion molecule-Ig fusion protein selectively targets activated alpha 4-integrin receptors in vivo. Inhibition of autoimmune diabetes in an adoptive transfer model in nonobese diabetic mice. Journal of immunology (Baltimore, Md. : 1950), 1995, Jul-15, Volume: 155, Issue:2 Topics: Animals; Antigens, CD; Autoimmune Diseases; Diabetes Mellitus, Type 1; Female; Immunoglobulins; Immunotherapy, Adoptive; Integrin alpha4; Islets of Langerhans; Lymphocyte Depletion; Manganese; Methotrexate; Mice; Mice, Inbred NOD; Receptors, Very Late Antigen; Recombinant Fusion Proteins; Vascular Cell Adhesion Molecule-1	1995
Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients. Arthritis and rheumatism, 1995, Volume: 38, Issue:8 Topics: Adult; Aged; Arthritis, Rheumatoid; Biopsy; Chemical and Drug Induced Liver Injury; Cost Savings; Diabetes Mellitus, Type 1; Drug Monitoring; Evaluation Studies as Topic; Female; Humans; Liver Diseases; Male; Methotrexate; Middle Aged; Practice Guidelines as Topic; Rheumatology; Risk Factors; United States	1995
A patient with a severe scleroedema diabeticorum, partially responding to low-dose methotrexate. Dermatology (Basel, Switzerland), 1999, Volume: 198, Issue:2 Topics: Adult; Dermatologic Agents; Diabetes Mellitus, Type 1; Female; Humans; Methotrexate; Scleredema Adultorum	1999
Good "negative results". Clinical immunology (Orlando, Fla.), 2000, Volume: 96, Issue:1 Topics: C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Insulin; Methotrexate; Publishing; Research Design	2000
Good "negative results". Clinical immunology (Orlando, Fla.), 2000, Volume: 96, Issue:2 Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Methotrexate; Publishing; Research Design	2000